Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Transition Award (R00)
Project #
3R00CA126160-04S1
Application #
7907337
Study Section
Special Emphasis Panel (ZCA1-RTRB-A (M1))
Program Officer
Sathyamoorthy, Neeraja
Project Start
2007-08-22
Project End
2010-07-31
Budget Start
2009-08-01
Budget End
2010-07-31
Support Year
4
Fiscal Year
2009
Total Cost
$28,143
Indirect Cost

  Institution

Name
Ohio State University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210

  Publications

Cui, Jiajun; Germer, Katherine; Wu, Tianying et al. (2012) Cross-talk between HER2 and MED1 regulates tamoxifen resistance of human breast cancer cells. Cancer Res 72:5625-34
Zhang, Chunpeng; Wang, Liguo; Wu, Dayong et al. (2011) Definition of a FoxA1 Cistrome that is crucial for G1 to S-phase cell-cycle transit in castration-resistant prostate cancer. Cancer Res 71:6738-6748
Wu, Dayong; Zhang, Chunpeng; Shen, Yanping et al. (2011) Androgen receptor-driven chromatin looping in prostate cancer. Trends Endocrinol Metab 22:474-80
Chen, Zhong; Zhang, Chunpeng; Wu, Dayong et al. (2011) Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth. EMBO J 30:2405-19
Wang, Hongyan; Zhang, Chunpeng; Rorick, Anna et al. (2011) CCI-779 inhibits cell-cycle G2-M progression and invasion of castration-resistant prostate cancer via attenuation of UBE2C transcription and mRNA stability. Cancer Res 71:4866-76
Chen, Zhong; Wang, Liguo; Wang, Qianben et al. (2010) Histone modifications and chromatin organization in prostate cancer. Epigenomics 2:551-60